South Riding, VA (PRWEB) October 20, 2022 Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies,
Hikma appoints Patrick Genestin to lead Generics Business Development
News provided by
Share this article
Share this article
LONDON, June 9, 2021 /PRNewswire/ Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that Patrick Genestin has been appointed Vice President, Business Development, Generics. Mr. Genestin brings to Hikma more than 25 years of experience in the pharmaceutical industry as a results-driven executive with strong financial, business development and M&A experience. He will be based at the company s US headquarters in Berkeley Heights, NJ.
In this role, Mr. Genestin is responsible for driving pipeline strategy and identifying new growth opportunities for Hikma s Generics business, including leading the execution of licensing and M&A deals, proactively identifying business development opportunities and maintaining and growing Hikma s contract manufacturing (CMO) business.